Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Cigarette smoking predicts differential benefit from naltrexone for alcohol dependence.

Fucito LM, Park A, Gulliver SB, Mattson ME, Gueorguieva RV, O'Malley SS.

Biol Psychiatry. 2012 Nov 15;72(10):832-8. doi: 10.1016/j.biopsych.2012.03.023.

2.

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A; COMBINE Study Research Group..

JAMA. 2006 May 3;295(17):2003-17.

PMID:
16670409
3.

Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.

Greenfield SF, Pettinati HM, O'Malley S, Randall PK, Randall CL.

Alcohol Clin Exp Res. 2010 Oct;34(10):1803-12. doi: 10.1111/j.1530-0277.2010.01267.x.

4.

Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients.

Zarkin GA, Bray JW, Aldridge A, Mitra D, Mills MJ, Couper DJ, Cisler RA; COMBINE Cost-Effectiveness Research Group..

Arch Gen Psychiatry. 2008 Oct;65(10):1214-21. doi: 10.1001/archpsyc.65.10.1214.

5.

Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes.

Donovan DM, Anton RF, Miller WR, Longabaugh R, Hosking JD, Youngblood M; COMBINE Study Research Group..

J Stud Alcohol Drugs. 2008 Jan;69(1):5-13.

PMID:
18080059
6.

Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study.

Mann K, Lemenager T, Hoffmann S, Reinhard I, Hermann D, Batra A, Berner M, Wodarz N, Heinz A, Smolka MN, Zimmermann US, Wellek S, Kiefer F, Anton RF; PREDICT Study Team..

Addict Biol. 2013 Nov;18(6):937-46. doi: 10.1111/adb.12012.

PMID:
23231446
7.

Baseline trajectories of drinking moderate acamprosate and naltrexone effects in the COMBINE study.

Gueorguieva R, Wu R, Donovan D, Rounsaville BJ, Couper D, Krystal JH, O'Malley SS.

Alcohol Clin Exp Res. 2011 Mar;35(3):523-31. doi: 10.1111/j.1530-0277.2010.01369.x.

8.

Cravings as a mediator and moderator of drinking outcomes in the COMBINE study.

Subbaraman MS, Lendle S, van der Laan M, Kaskutas LA, Ahern J.

Addiction. 2013 Oct;108(10):1737-44. doi: 10.1111/add.12238.

9.
11.

Effect of the combination of naltrexone and acamprosate on alcohol intake in mice.

Kim SG, Han BD, Park JM, Kim MJ, Stromberg MF.

Psychiatry Clin Neurosci. 2004 Feb;58(1):30-6.

12.

Naltrexone for the treatment of alcohol dependence among African Americans: results from the COMBINE Study.

Ray LA, Oslin DW.

Drug Alcohol Depend. 2009 Dec 1;105(3):256-8. doi: 10.1016/j.drugalcdep.2009.07.006.

13.

An intervention for treating alcohol dependence: relating elements of Medical Management to patient outcomes with implications for primary care.

Ernst DB, Pettinati HM, Weiss RD, Donovan DM, Longabaugh R.

Ann Fam Med. 2008 Sep-Oct;6(5):435-40. doi: 10.1370/afm.884.

14.

A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone.

Mason BJ, Goodman AM, Dixon RM, Hameed MH, Hulot T, Wesnes K, Hunter JA, Boyeson MG.

Neuropsychopharmacology. 2002 Oct;27(4):596-606.

15.

Do patients with alcohol dependence respond to placebo? Results from the COMBINE Study.

Weiss RD, O'malley SS, Hosking JD, Locastro JS, Swift R; COMBINE Study Research Group..

J Stud Alcohol Drugs. 2008 Nov;69(6):878-84.

16.

What happens when people discontinue taking medications? Lessons from COMBINE.

Stout RL, Braciszewski JM, Subbaraman MS, Kranzler HR, O'Malley SS, Falk D; ACTIVE group..

Addiction. 2014 Dec;109(12):2044-52. doi: 10.1111/add.12700.

17.
18.

Relationship between medication adherence and treatment outcomes: the COMBINE study.

Zweben A, Pettinati HM, Weiss RD, Youngblood M, Cox CE, Mattson ME, Gorroochurn P, Ciraulo D.

Alcohol Clin Exp Res. 2008 Sep;32(9):1661-9. doi: 10.1111/j.1530-0277.2008.00743.x.

19.

Simultaneous modeling of the impact of treatments on alcohol consumption and quality of life in the COMBINE study: a coupled hidden Markov analysis.

Prisciandaro JJ, DeSantis SM, Bandyopadhyay D.

Alcohol Clin Exp Res. 2012 Dec;36(12):2141-9. doi: 10.1111/j.1530-0277.2012.01823.x.

20.

Which treatment for alcohol dependence: naltrexone, acamprosate and/or behavioural intervention?

Doggrell SA.

Expert Opin Pharmacother. 2006 Oct;7(15):2169-73.

PMID:
17020440
Items per page

Supplemental Content

Support Center